Showing posts with label Pharmaceutical. Show all posts
Showing posts with label Pharmaceutical. Show all posts

Wednesday, 23 July 2014

Collagen Peptide Market - Global Industry Research Report, 2014-2020

Posted on 04:13 by Unknown
Collagen peptide is a natural body protein, which is produced inside the body and is a primary constituent of the fibrous connective tissue found in skin, bones, and cartilage. Initially collagen and elastin are produced in the body to prevent dermal layers of skin from developing skin folds. These substances create collagen peptide bundles that results in firm skin of the body. Additionally, these proteins play an important role in keeping the dermal layers of skin healthy. When these collagen peptide bundles decrease, the appearance of skin wrinkles turns out to be more evident. To address these challenges, most of the pharmaceutical and skin care companies started manufacturing collagen creams, injections and capsules with an intention to produce smoother and healthier skins of all ages. Collagen peptide is used in pharmaceutical, food, dietary supplements, and cosmetic industries. They have various application segments such as in sports performance, weight management, skin health, and joint and bone health. These products typically manufactured as fragrance-free and hypo-allergic skin care products.
Read More @ http://www.transparencymarketresearch.com/collagen-peptide.html
Collagen peptide has a huge growth potential based on its applications in cosmetics, and bone and joint health. Increase in the numbers of aging population around the world as well as the increasing incidence of bone and joint ailments is fueling the demand for collagen peptide. Current major trend of younger looking skin and the increase in consumer awareness about the benefits of collagen peptide are expected to increase the consumption of the collagen peptide enriched foodstuffs and dietary supplements.
According to the American Academy of Orthopedic Association (AAOS), almost 80% of the world’s hip fractures are attributed to osteoporosis and this percentage is expected to increase in coming years. Currently, over 27% of world’s population is being affected with osteoporosis, especially in females in the post-menopausal stage. These contributing factors are likely to increase the market for collagen peptide as a savior in making those joints stronger. However, at present, there is a lack of awareness in the end user market regarding the use of collagen peptide in terms of skin and bone ailments. In the light of this problem manufacturers are expected to prove the efficacy of collagen peptide by showing the results of human clinical studies. Bovine is the major source of raw material used for the collagen peptide production followed by fish and pork.
The market for collagen peptide can be segmented based on type of sources and by application. Based on type of sources, the market is classified into bovine, porcine, chicken, marine and others, whereas, the based on type of application, the market can be segmented into bone and joint health, nutraceuticals, cosmeceuticals, pet food, pharmaceuticals and others.
Bone and joint health application segment of collagen peptide is facing a competition from the existing well-known ingredients such as glucosamine and chondroitin sulfate which has proven results in osteoporosis treatment. Bone and joint health (Osteoporosis) is the major application segment followed by cosmeceuticals, dietary supplements and pet food. The collagen peptide market is geographically segmented into Asia-Pacific, Japan, North America and South America and Europe. China and Japan are the most popular areas and increasing in awareness of the benefits of collagen peptide in cosmetics, where as in Europe bone health is the most popular application of collagen peptide.
Geographically, North America accounts for the largest share of the collagen peptide market followed by the European region. The dominance of North America in this market is seen due to rapidly aging population who can afford high cost of treatment and presence of various market leaders, which allows easy penetration in the North America region. Additionally, growing healthcare awareness among the population and rising number of osteoporosis patients further driving the growth of this market. However, Asia-Pacific region is expected to witness fastest growth rate in the near future due to improving purchasing power and the westernization of diets, increase in people’s standards of living in the emerging economies like India and china are expected to create more demand for collagen peptide market. Innovation in the collagen peptide application in pet food will create more opportunities in future
Some of the key participants in the market are Amicogen, Inc., Rousselot International, Nitta Gelatin, Reinert Gruppe Ingredients, Ewald Gelatine, Trobas Gelatine, Gelatines Weishardt, PB Gelatins, Gelita, BioCell Technology and others.
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
  • North America
  • Asia Pacific
  • Europe
  • Rest of the World
This report provides comprehensive analysis of
  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years

About Us
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

Contact:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453

Browse Market Research Blogs:

Posted in , , , | No comments

Monday, 16 June 2014

Research on Alzheimer's Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2012 - 2018

Posted on 02:45 by Unknown
Alzheimer's Drugs Market
Alzheimer’s disease is a neurological disorder of the brain which is progressive and ultimately leads to loss of neurons. This condition leads to loss of memory and reasoning abilities. Currently, there is no treatment for Alzheimer’s, although there are certain ways of slowing down its progression. Physicians generally prescribe neurotransmitters like cholinesterase inhibitors, memantine, etc. to slow down the advancement of disease and improve some symptoms such as insomnia, depression, anxiety and agitation.


The global Alzheimer’s drugs market is expected to show a sluggish growth in coming years due to lack of significant facilities for disease diagnosis and treatment. North America held the majority of market share covering more than half of the market. However, this market has immense growth opportunities in the emerging economies of Asia-Pacific such as India, China, Russia and Australia due to prevalence of unmet medical needs. The increase in aging population serves as a major driver of Alzheimer’s drugs and treatment market. Unmet medical needs had led to the focus on the area of research and development which ultimately results in new product introduction and hence contributes to the market growth.

Early diagnosis of Alzheimer’s disease is not possible and there is a strong need of early detection techniques. Expiry of several patents could pose a serious threat in the growth of this market. Some of the major players in the Alzheimer’s drugs market include companies such as Forest Laboratories, Inc., Eisai Co., Ltd., H. Lundbeck A/S., Novartis AG, Pfizer Incorporation and others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
·         North America 
·         Asia Pacific 
·         Europe
·         Rest of the World  

This report provides comprehensive analysis of 
·         Market growth drivers 
·         Factors limiting market growth
·         Current market trends 
·         Market structure
·         Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 


About us

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.




Contact Us

Sheela AK
Corporate Office:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States.

Tel: +1-518-618-1030

Browse Market Research Blogs:
Posted in , , , | No comments

Wednesday, 21 May 2014

Autism Spectrum Disorder Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2013 - 2019

Posted on 00:36 by Alina Martin
Pharmaceuticals copy
Autism spectrum disorder (ASD) is a group of multifaceted neurodevelopment disabilities characterized by social, behavioral and communication challenges. This condition is characterized by communication difficulties, social impairment and repetitive and stereotyped behavioral patterns. It is a spectrum condition because while all people affected with autism share some similar difficulties, the level of medical condition affects them in different ways. Symptoms of ASD vary widely and it may sometimes go unrecognized especially in mildly affected children. Early indicators include loss of language or social skills, lack of response, poor eye contact, no single words or two-word phrases by the age of 2 years. If left unrecognized by the age of 3 years, one may recognize later through impaired ability to make friends, stereotyped or unusual use of language, inability to initiate or withstand a conversation with others; varying specific routines or rituals and impairment or absence of imaginative and social interactions.
Presently, there are no medications that can treat ASD or its core symptoms. It is an underserved market with only two FDA approved drugs Abilify (aripiprazole) and risperidone. These drugs belong to the anti-psychotics therapeutic class, but are approved for the treatment of irritability associated with autistic disorder. Besides, certain other classes of drugs such as antidepressants, anticonvulsants and stimulants are prescribed off-label for reducing autism related neurological challenges.
Patent expiration of Abilify will lead to decline in the market growth which is expected to offset by new introductions which may improve the therapeutic benefits. The growth of this market is primarily attributed to the increasing prevalence of ASD. According to CDC, average prevalence of ASD in Asia, Europe and North America is 1%. Further, the estimates state that the prevalence rate has risen form 1 in 150 children in 2000 to 1 in 68 children in 2010.
Abilify is a product of Bristol-Myers Squibb and Otsuka Holdings Co., Ltd. While, risperidone is a generic market with many key players such as Janssen Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Actavis, Inc., Mylan Pharmaceuticals, Inc., Ranbaxy Laboratories Limited and Sun Pharmaceutical Industries Limited.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
  • North America
  • Asia Pacific
  • Europe
  • Rest of the World
This report provides comprehensive analysis of 
  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
About us
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.
Contact Us
Sheela AK
Corporate Office:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States.
Posted in , , , | No comments

Monday, 12 May 2014

Human Reproductive Technologies Market - Global Industry Analysis, Size, Procedures, Growth, Trends and Forecast, 2013 – 2019

Posted on 03:10 by Alina Martin
Human reproductive technologies are used to conceive pregnancy by means of artificial or partially artificial medical procedures. These technologies are primarily used in infertility treatments. Reproductive technologies involve collecting and storing sperm and eggs below 0°C for artificial insemination and in vitro fertilization.

Browse the full report with request TOC at
http://www.transparencymarketresearch.com/human-reproductive-technologies.html

Currently, North America dominates the global human reproductive technologies market and is followed by Europe due to emerging of number of clinics specializing in aiding the reproductive procedures in these regions. Emerging economies of Asia-Pacific, Latin America and the Middle East are also expected to exhibit rapid growth in this market due to rapid adoption of technological advances in fertility treatments.

Get  free report sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1876

The major factors driving the human reproductive technology market include the rising demand and willingness to adopt new scientific technologies by people allowing infertile couples to create biologically-related children. However the concerns regarding financial and bioethical issues may pose a challenge to the market growth for human reproductive technologies.

Some of the key players contributing to the global human reproductive technologies market include Bayer AG, Berlex Laboratories, Inc., Bristol-Myers Squibb Co., Church & Dwight Company, Inc., Eli Lilly & Co., Endocare, Inc., GlaxoSmithKline PLC, Icos Corp., Novartis International AG, Organon international, Inc., Ortho-Mcneil Pharmaceutical, Inc., Pfizer, Inc., Princeton Biomeditech Corp., Serono S.A., Vivus, Inc. and Watson Pharmaceuticals, Inc.

Related Report:  

Green Energy Market: http://www.transparencymarketresearch.com/green-energy-market.html
This research report analyzes this market depending on its market segments, major geographies, and current market trends.
Geographies analyzed under this research report include
  • North America 
  • Asia Pacific 
  • Europe 
  • Rest of the World
This report provides comprehensive analysis of
  • Market growth drivers 
  • Factors limiting market growth 
  • Current market trends 
  • Market structure 
  • Market projections for upcoming years
Technologies
  • Assisted reproductive technology 
  • Contraception 
  • Prognostics 
  • Others 
  • Application 
  • Therapeutics 
  • Diagnosis 
  • Devices 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Browse all Market Research reports:
http://technologyandmediaresearch.blogspot.ca/
http://mrreports.wordpress.com/
http://sandyresearcher.wordpress.com/

 About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:sales@transparencymarketresearch.com
Web: http://www.transparencymarketresearch.com/
Blog: http://www.tmrblog.com/

Browse Market Research News: http://www.transparencymarketresearch.com/press-releases.htm
Browse Market Research Articles: http://www.transparencymarketresearch.com/articles.htm
Posted in , , , | No comments

Thursday, 8 May 2014

Cystic Fibrosis Therapeutics Market - Global Industry Analysis, Size, Share, Trends and Forecast, 2013 – 2019

Posted on 02:34 by Unknown
Transparency Market Research Reports included a detailed market survey and analysis trends on “Cystic Fibrosis Therapeutics Market”. This report also includes more info about basic overview of the industry including definitions, applications and global market industry structure. Cystic fibrosis (CF), also known as mucoviscidosis, is autosomal recessive disorder that is characterized by abnormal transport of chloride and sodium across an epithelium. The occurrence of disease leads to thick and viscous secretions which causes a life threatening impact on the lungs, the pancreas, liver, and intestine, and also blocks the pancreatic enzymatic actions on the body. Cystic fibrosis is caused by mutation in gene, required for protein cystic fibrosis transmembrane conductance regulator (CFTR), a protein required for regulating sweat, mucus and body secretions. 

Browse Full Report with TOC: http://www.transparencymarketresearch.com/cystic-fibrosis-therapeutics.html

The market for CF therapeutics is segmented on the basis of therapeutic products such as Pulmozyme, TOBI, Kalydeco, Cayston, Aeroquin, Arikace and others. Further, the market is also segmented on the basis of geography, such as North America, Europe, Asia-Pacific and Rest of the World (RoW). The European market is considered as most lucrative market for CF Therapeutics, followed by the North American Market. However, Asia-Pacific is considered as the least important market, owing to least prevalence of the disorder.

The market for CF Therapeutics is projected to show a promising and lucrative growth in the next few years due to continued R&D activities in this field. At present, there are more than 30-40 drugs (including bronchodilators, antibiotics, NSAIDs, steroids and others) available in the market. Further owing to continued extensive research and development activities, a variety of medicines are expected to launch in the market in future period. Increasing global awareness for cystic fibrosis therapy, technological advancements in the R&D and increase in the prevalence of cystic fibrosis are some of the factors estimated as the major drivers for CF Therapeutics Market. However, complicated pathophysiology, high cost of treatment and R&D and increase in genetic mutation rate are some of the factors expected to hinder the growth of this market.

Some of the major players operating in this market includes Novartis International AG, ChiesiFarmaceuticiSpA, Vertex Pharmaceuticals, Genentech, Inc., and Gilead Sciences, Inc. amongst others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

Reasons for Buying this Report

  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
·   More Reports On Pharmaceutical Market: - http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About Us:-

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

Contact Us

Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Browse Market Research Report:-
http://www.tmrblog.com/

http://marketingfirmblog.wordpress.com/
Posted in , , , , , | No comments

Wednesday, 30 April 2014

Weight Management Products Market – Global Industry Strategic Report, 2010-2017

Posted on 00:13 by Unknown
Transparency Market Research Reports incorporated a definite business overview and investigation inclines on "Weight Management Products Market". This report likewise incorporates more illumination about fundamental review of the business including definitions, requisitions and worldwide business sector industry structure.

The need to stay fit and agile has led to an increase in the number of gymnasiums and other weight loss facilities across the globe, thus driving the market for weight management products. Among the two methods of weight loss dieting and physical exercise, latter is considered more effective and sustainable. United States accounts for the maximum number of obese people worldwide. Obesity is increasing like a epidemic across the globe, thus driving the need for weight management products globally.

Browse Full Report with TOC: http://www.transparencymarketresearch.com/weight-management-products-market.html

The report contains the global scenario of Weight Management Products market discussing detailed overview and market figures. The research report analyses the industry growth rate, industry capacity, and industry structure. The report analyses the historical data and forecasts the Weight Management Products market size, production forecasts along with key factors driving and restraining the market.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

More Reports on Pharmaceutical Market:  http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About Us:-

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers. 

Contact Us 
Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com 
Website: http://www.transparencymarketresearch.com/ 

Browse Market Research Report:- 
http://www.tmrblog.com/ 

http://marketingfirmblog.wordpress.com/
Posted in , , , , , , , | No comments

Wednesday, 23 April 2014

Connected Device Management Platform Market - Global Industry Analysis, Size, Trends And Forecast, 2013 - 2019

Posted on 04:35 by Unknown
Connected device management (CDM) platforms are used to automate the management and provision of machine to machine (M2M) module connectivity. CDM platforms are critical for providing the value added attributes in the Internet of Things (IoT) architecture. The platforms exist within Big Data, IT cloud platforms, analytics and other intelligent devices. CDM platforms act as a bridge between higher layers of architecture and the connected devices.

Browse Full Report with TOC: 
http://www.transparencymarketresearch.com/connected-device-management-platform.html

The growing use of cloud based technology, Big Data and analytics has stimulated the demand for these platforms. Applications developed in CDM platforms capable enough to process raw data into usable information. Additionally, CDM platforms  provide insulation against direct device connection which may affect the internal architecture. Owing to this, the dependency on the CDM platforms has increased significantly. However, network compatibility issues, ecosystem complexity and adequate advancement in technology posses a key challenge for this market. CDM platforms offers M2M providers to add value and earn margins by selling embedded hardware and applications enablement .  CDM platform are used in various industries including transportation and logistics, retail, water and wastewater, oil and gas, industrial machinery, healthcare, energy, consumer, automotive and building automation. 

North America is dominating the market followed closely by Europe. The growth is attributed to the technological advancements in communication and network infrastructure. Asia-Pacific is expected to observe a significant growth in the near future. The growth is attributed to the strong IT infrastructure and deep penetration of telecommunication networks.

Some of the key players operating in CDM platforms market include Axeda Corp., ILS Technologies LLC, ThingWorx Inc., Sierra Wireless Inc., Raco Wireless LLC, Wind River Systems Inc., Jasper Wireless Inc., Comarch S.A., Qualcomm Inc., SensorLogic Inc., Echelon Corp., Ziphany LLC, Tridium Inc., Augusta Systems Inc., Palantiri Systems Inc., Crossbow Technology Inc., nPhase LLC, Wyless Inc., Feeney Wireless LLC, Kore Telematics Inc. and Numerex Corp. among others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

More Reports on Technology and Media Market: 
http://www.transparencymarketresearch.com/technology-market-reports-8.html

About Us:-
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

Contact Us
Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Browse Market Research Report:-
http://www.tmrblog.com/

http://marketingfirmblog.wordpress.com/
Posted in , , , , , | No comments

Mental Disorders Drugs Market - New Industry Research Report

Posted on 02:42 by Unknown
A mental disorder is a psychological anomaly that is reflected in the behavior of the patient through distress, disability or any conduct that is not a part of a person’s normal mental development. The causes of mental disorders are varied in nature and many are also unclear. Psychiatric medication and psychotherapy are the two modes of treatment for mental disorder. In psychiatric medication drug classes such as antidepressants, anxiolytics, and antipsychotics are most commonly used. 

Browse Full Report with TOC: http://www.transparencymarketresearch.com/mental-disorders-drugs.html

Improvement in patient security policy, growth in domestic and foreign investment in the field of mental medication, and increase in the prevalence and the related awareness about mental health are the major drivers for the global mental disorders drugs market. However, skepticism about social pressure regarding mental diseases and their treatment, especially in less advanced countries, and the lack of government initiatives in such locations may hold back the growth of this market.

The overall mental disorders drugs market can be classified on the basis of the mental drugs such as antidepressants, antipsychotics, anxiolytics, drugs for schizophrenia, drugs for childhood and adolescent mental illness, and drugs for the treatment of  substance and alcohol addiction, bipolar disease drugs, and others.

North America is the largest market for mental disorders drugs. Factors such as increasing government initiatives, better reimbursement policies, and general awareness about mental health and treatment are responsible for the growth of this market in this region. An increase in the awareness about the efficacy of mental disorders’ drugs and growth in the related clinical evidence will assist in the rapid growth of this market in Asia-Pacific. The major players in the mental disorders drugs market include pharmaceutical manufacturers such as Eli Lilly, AstraZeneca, Pfizer, Johnson and Johnson, GlaxoSmithKline, and Bristol-Myers Squibb.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

More Reports on Pharmaceutical Market: 
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About Us:-
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

Contact Us
Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Browse Market Research Report:-
http://www.tmrblog.com/

http://marketingfirmblog.wordpress.com/
Posted in , , , , , , , , | No comments

Wednesday, 9 April 2014

Organ And Tissue Transplantation And Alternatives Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 – 2019

Posted on 23:28 by Alina Martin
Pharmaceuticals copy
Organ transplantation is the process of transplant of an organ from one body to another or from donor site to another recipient site for the purpose of replacing the damaged or absent organ.  Organ transplantation is the last therapeutic option for the treatment in the final stage of organ failure. Organs that can be transplanted are heart, kidney, liver, lungs, pancreas, intestine, and thymus. Tissues that can be transplanted include bones, tendons, cornea, skin, heart valves, nerves and veins.
Organ and tissue transplantation is a rapidly growing field due to increasing prevalence of organ and tissue failure diseases. Better harvesting and procurement techniques, vastly improved immunosuppression regimens, advance tissue matching and effective anti-infective regimens are also supporting the growth of organ and tissue transplantation market. Lack of artificial organs and organ donors pose a major challenge for the industry. However, increasing investments on research and development are expected to bring better opportunities for the market.
The market of organ and tissue replacement can be divided in to various parts, such as tissue typing technology, solid organ procurement and preservation, tissue products, immunosuppressant, post translational monitoring of tissue and organ and alternative devices and technologies. Tissue typing technologies include panel typing reactive and sequence typing. Solid organ procurement and preservation comprises organ procurement in different regions of the world, such as the U.S., EU, Japan and China. Tissue products segments include various transplant products, such as heart valve, stem cells and bone matrix products. Alternative devices and technologies include devices for corneal, intestinal and pancreas transplantation.
Some of the major players in the market of organ and tissue transplantation are Abbott, Arthrex, Bristol-Myers, Biomet, Celera, Centacor and Novartis.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
  • North America
  • Asia Pacific
  • Europe
  • Rest of the World
This report provides comprehensive analysis of 
  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
About us
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.
download-pdf (1)
Contact Us
Sheela AK
Corporate Office:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States.
Posted in , , , , | No comments
Subscribe to: Posts (Atom)